The future of protein production live October 2024 Amsterdam

« Previous article
IFF's 'Nouri...
Next article »
VITATEX® Vegan-S...

24th August 2022  Product update: newprotein staff writer

Kalsec Partners With Infinome to Develop & Manufacture Precision Fermentation Products

Infinome™ Biosciences and Kalsec® Inc, have entered into a new partnership to develop and commercialize multiple precision fermentation products. The partnership will deliver naturally produced, highly innovative ingredients with superior quality and consistency, in the most sustainable way possible.

Infinome’s GenoScaler™ is a proprietary, ultra-high-throughput, CRISPR-enabled strain engineering platform designed to rapidly optimize microbial strains with vastly improved traits and productivities. Infinome will employ GenoScaler™ to develop ingredient-producing strains and provide Kalsec with these ingredients to validate their performance in food applications.

Kalsec’s long history and expertise in creating natural products and solutions for the food and beverage industry will enable it to maximize the benefits of Infinome’s microbial strain engineering platform. By working closely with their customers, the development team at Kalsec has identified multiple large product opportunities. R&D teams at Infinome will work with Kalsec to develop sustainable biomanufacturing processes through accelerated strain engineering and process development.

“Infinome’s GenoScaler™ is a complete, end-to-end microbial manufacturing platform based on several breakthrough technology developments,” said Dr. Richard Fox, Infinome co-founder and CEO/CTO. “Our goal at Infinome is to enable more companies to access the bioeconomy by accelerating the development and reducing the risk and complexity of biomanufacturing. Through advanced technology, strategy, and processes, we are helping to create sustainable solutions with long-term partners like Kalsec.”

Visit Kalsec or Infinome Biosciences or use the Request Information button below.



Date Published: 24th August 2022

Source article link: View

Note: This content has been edited by a staff writer for style and content.

View full company details

Related news